H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $36

Futu NewsNov 21 19:31 · Ratings

Buy Rating on RegenXBio Driven by Positive RGX-202 Trial Results and Strong Approval Prospects

TipRanksNov 21 19:16 · Ratings

Express News | Regenxbio Inc. : H.c. Wainwright Cuts Target Price to $36 From $40

BreakingsNov 21 19:05

Barclays Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $50

Futu NewsNov 21 18:34 · Ratings

REGENXBIO Is Maintained at Buy by Chardan Capital

Dow JonesNov 20 19:11 · Ratings

REGENXBIO Price Target Maintained With a $52.00/Share by Chardan Capital

Dow JonesNov 20 19:11 · Ratings